MIND Diet to Improve Cognitive Function in Mild Stroke Patients (MINDICOMS) II

NCT06331247 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-04

No results posted yet for this study

Summary

A 6-month pilot randomized controlled trial designed to test the effect of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet + usual medical care versus usual medical care on cognitive change and several other secondary outcomes through a randomized controlled trial in 60 mild stroke patients aged 35-70 years without dementia.

Conditions

  • Dementia
  • Stroke
  • Cognitive Change
  • Cerebrovascular; Disorder, Thrombotic

Interventions

BEHAVIORAL

General dietary advice

General dietary advice according to the Chinese Dietary Guidelines 2022.

BEHAVIORAL

Localized MIND diet intervention

The MIND diet intervention, composed of the consumption of whole grains, dark green leafy vegetables, dark red/yellow vegetables, other vegetables, berries and citrus, poultry, fish and seafoods, beans and legume, nuts, olive and seed oils, and green tea, and restricting red and processed meats, animal fat, fried foods, and sweets and pastries.

OTHER

Routine medical care

Routine medical care and follow-ups.

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Changzheng Yuan, ScD · Second Affiliated Hospital, Zhejiang University School of Medicine

  • Lusha Tong, MD · Second Affiliated Hospital, Zhejiang University School of Medicine

  • Xin Xu, PhD · Zhejiang University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-18
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06331247 on ClinicalTrials.gov